Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era
Anand Patel(Ascension), Olatoyosi Odenike(University of Chicago), Ellen Madarang(University of Miami), Madelyn Burkart(Atrium Health Wake Forest Baptist), Yasmin Abaza(Northwestern University), Marta Davidson(Princess Margaret Cancer Centre), Joshua Kassner(Memorial Sloan Kettering Cancer Center), John Cursio, Rafael Madero‐Marroquin(University of Chicago), Hannah Johnston(University of Illinois Chicago), Timothy S. Oh(Northwestern University), Evan C. Chen(Dana-Farber Cancer Institute), Iyana Gross(University of Chicago), Kristen Pettit(University of Michigan), Terrence Bradley(University of Miami Health System), Vikas Gupta(Indian Institute of Technology Kanpur), Auro Viswabandya(Princess Margaret Cancer Centre), James Yoon(Beth Israel Deaconess Medical Center), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Sunil Iyer(University of Miami), Chandrasekar Muthiah(Medical College of Wisconsin), Rory M. Shallis(Smilow Cancer Hospital), Jacqueline S. Garcia(Dana-Farber Cancer Institute), Raven Dean(University of Chicago), Guru Subramanian Guru Murthy(Medical College of Wisconsin)
Cited by 32
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304